Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
10/2002
10/29/2002US6472544 Process for the preparation of optically active 2-[6-hydroxymethyl)-1,3-dioxan-4yl]acetic acid derivatives
10/29/2002CA2071669C Aminophenoxyalkyl derivatives of benzodioxan
10/24/2002WO2002083661A1 Glycolide production process, and glycolic acid oligomer for glycolide production
10/24/2002US20020156075 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
10/23/2002CN1375493A Dioxy methane derivatives
10/22/2002US6469005 Propargylether derivatives
10/16/2002EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002EP1248761A1 Compounds which mimic the chemical and biological properties of discodermolide
10/16/2002EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002EP1248607A1 Urotensin-ii receptor antagonists
10/16/2002EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002CN1374958A Process for the preparation of cyclic lactic acid oligomers
10/16/2002CN1374287A Process for producing 2.7-dimethyl-2,4,6-sarohornene aldehyde mono aldehyde acetal
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002WO2002079124A2 Method of producing high yield alditol acetals with mineral acids and surfactants
10/10/2002WO2002057251A3 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
10/10/2002CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002EP1247808A2 Continuous process for the manufacture of lactide and lactide polymers
10/09/2002EP1246820A1 Novel heteroaryl derivatives, their preparation and use
10/09/2002EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002EP0964856B1 Bicyclic amino acids
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/08/2002US6462223 Reacting a 6-halomethyl-4h-1,3-dioxin-4-one derivative with carbon monoxide and an alcohol or water
10/08/2002US6462077 Thromboxane ligands without blood clotting side effects
10/08/2002CA2220995C New derivatives of substituted 7,12-dioxa-benzo¬a|anthracenes, their preparation process and the pharmaceutical compositions they contain
10/03/2002WO2002076972A1 Novel dioxin analogues and methods and kits for searching out dioxin-decomposing organisms or emzymes or dioxin-decoposing enzyme genes
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002058631A3 Primary intermediates for oxidative coloration of hair
10/03/2002US20020143203 Cosmetic compositions for protecting skin and hair and for technical applications, ultraviolet radiation filters
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020143130 Monomer and polymer for photoresist, photoresist composition, and phosphor layer composition for color cathode ray tube
10/03/2002US20020143036 Pentafluorobenzenesulfonamides and analogs
10/02/2002EP1245660A2 Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices
10/01/2002US6458785 Aids therapy
09/2002
09/26/2002WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002US20020137953 Method of producing high yield alditol acetals with mineral acids and surfactants
09/26/2002US20020137789 Anticancer agents
09/26/2002CA2439539A1 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/25/2002EP1001951B1 Thiazole derivatives, method for their production and use
09/19/2002WO2002072567A2 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/19/2002US20020132970 Exposure to high energy radiation
09/19/2002US20020132967 Reacting ammonium lactate with ethanol in aqueous solution
09/19/2002US20020130300 For use in liquid-crystal and electro-optical display elements
09/19/2002DE10112067A1 Verfahren zur Herstellung von 2,7-Dimethyl-2,4,6-octarienal-monoacetalen Process for the preparation of 2,7-dimethyl-2,4,6-octarienal-monoacetals
09/19/2002DE10111065A1 Verbessertes Verfahren zur Herstellung von ungesättigten cyclischen Ethern An improved process for preparing unsaturated cyclic ethers
09/18/2002EP1241157A1 Process for the preparation of 2,7-dimethyl-2,4,6-octatrienal-monoacetals
09/18/2002CN1369490A Mfg. Method of cyclic diester using fermented lactic acid as raw material and method for mfg. polylactic acid
09/18/2002CN1369475A Method for prodn. of dimethylol carboxylic acid
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451829 Coumarinic compounds having IgE affecting properties
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/12/2002WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof
09/12/2002WO2002070508A2 Glycolide production process, and glycolic acid composition
09/12/2002WO2002070128A1 Improved method for producing unsaturated cyclic ethers
09/12/2002US20020128519 Condensing an ester phosphonium salt or an ester phosphonate with an aldehyde in a Wittig or Wittig-Horner reaction to give an acetal ester, reducing the ester to give an acetal alcohol, oxidizing the alcohol to the monoacetal
09/12/2002US20020128266 ABCA-1 elevating compounds
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002CA2439849A1 Antagonists of mcp-1 function and methods of use thereof
09/10/2002US6448244 Broad-spectrum antifungals, against which there is no existing resistance and which can be administered intravenously or transungually
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides
09/05/2002DE10110307A1 Tricyclic compounds useful as components in liquid crystal media are new
09/03/2002US6444279 Liquid crystal propene or propenyl nitrile derivatives
09/03/2002US6444278 2,6-di-tert-butylphenols
08/2002
08/29/2002US20020120168 Difluoromethyl ether derivative and process for producing the same
08/29/2002US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
08/29/2002US20020117650 Dialkyne compounds
08/28/2002EP1234822A1 Methylene dioxy derivatives
08/28/2002EP1234186A1 Stabilizing a luminescent acridinium compound
08/28/2002EP1233956A1 Bryostatin analogues, synthetic methods and uses
08/27/2002US6441243 Forming ketones, aldehydes
08/27/2002US6441236 Hydrolysis, amination
08/27/2002US6441032 Treating systemic lupis and multiple sclerosis
08/22/2002WO2002064582A1 Process for producing 2,5-dihydroxy-1,4-dioxane
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/20/2002US6436914 2-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonists
08/20/2002US6436868 Composite catalyst composition for inhibiting generation of dioxin
08/15/2002WO2002062777A2 Amino ceramide-like compounds and therapeutic methods of use
08/15/2002US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
08/15/2002US20020111364 ABCA-1 elevating compounds
08/15/2002US20020111335 Bactericides, bacteriostats
08/15/2002US20020111268 Vanadium on alumina catalyst support
08/13/2002US6433008 Treating parkinson*s, alzheimer*s, autoimmune and rheumatic diseases; human immunodeficiency virus (hiv) dementia, and inflammation
08/13/2002US6432947 N-heterocyclic derivatives as NOS inhibitors
08/13/2002CA2115472C Melt crystallization purification of lactides
08/08/2002WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/08/2002WO2002006189A3 Aniline derivatives
08/08/2002WO2001092991A3 Design of polyketide synthase genes
08/08/2002US20020107417 Production of dimethylolcarboxylic acid
08/08/2002CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/07/2002EP1229013A2 Production of dimethylolcarboxylic acid
08/07/2002EP1229010A1 Novel diarylamide derivatives and use thereof as medicines
08/07/2002EP1228163A1 Ester compounds and their use in liquid crystalline media
08/07/2002EP1077976B1 Water soluble azoles as broad-spectrum antifungals
08/07/2002EP0638112B1 Liquid crystal compounds having perfluoroether terminal portions
08/01/2002WO2002059132A1 Intermediate compounds useful for making antiviral compounds
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 103